HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: M500096-JLR200v1 46/10/2168    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yoshida, S. Articles by Wada, Y. Search for Related Content PubMed PubMed Citation Articles by Yoshida, S. Articles by Wada, Y. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol. 46, 2168-2174, October 2005
Copyright © 2005 by American Society for Biochemistry and Molecular Biology

Transfer of maternal cholesterol to embryo and fetus in pregnant mice

Shumi Yoshida^1,* and Yoshinao Wada^*,

^* Graduate School of Medicine, Osaka University, Suita 565-0871, Japan
Department of Molecular Medicine, Osaka Medical Center and Research Institute for Maternal and Child Health, Izumi 594-1101, Japan

Published, JLR Papers in Press, August 1, 2005. DOI 10.1194/jlr.M500096-JLR200

¹ To whom correspondence should be addressed. e-mail: s-yoshida{at}mch.pref.osaka.jp

Cholesterol is essential for antenatal development. However, the transport of maternal cholesterol to the embryo has not been sufficiently studied, and that to the fetus is still controversial. To this end, a 1 mg dose of [3,4-¹³C₂]cholesterol was injected daily into pregnant mice and the labeled cholesterol was measured by gas chromatography-mass spectrometry. After venous injections from days 10 to 17 of gestation, [¹³C]cholesterol levels in total (¹²C and ¹³C) cholesterol were increased to 5.1% and 2.8% in maternal and fetal plasma, respectively. Labeled cholesterol was identified in the liver, kidneys, and intestines, but not in the brain, of the fetus. After injections from days 1 to 8, [¹³C]cholesterol levels were increased to 12.4% and 8.0% of total cholesterol in maternal plasma and the embryo, respectively. The level of 11.5% in the yolk sac was higher than that in the embryo.

Intrauterine transfer of maternal cholesterol to the embryo as well as the fetus was evident in mice, and both the placenta and the yolk sac appear to be sites of intermediate passage in murine pregnancy.

Supplementary key words placenta • fetus • yolk sac

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. M. Elahi, F. R. Cagampang, F. W. Anthony, N. Curzen, S. K. Ohri, and M. A. Hanson Statin Treatment in Hypercholesterolemic Pregnant Mice Reduces Cardiovascular Risk Factors in Their Offspring Hypertension, April 1, 2008; 51(4): 939 - 944. [Abstract] [Full Text] [PDF]

				F. Jiang and G. E. Herman Analysis of Nsdhl-deficient embryos reveals a role for Hedgehog signaling in early placental development Hum. Mol. Genet., November 15, 2006; 15(22): 3293 - 3305. [Abstract] [Full Text] [PDF]

				G. S. Tint, H. Yu, Q. Shang, G. Xu, and S. B. Patel The use of the Dhcr7 knockout mouse to accurately determine the origin of fetal sterols J. Lipid Res., July 1, 2006; 47(7): 1535 - 1541. [Abstract] [Full Text] [PDF]